Wells Fargo analyst Chris Carey raised the firm’s price target on Procter & Gamble to $170 from $165 and keeps an Overweight rating on the shares. The firm said in a research note on Friday that the differentiation of Procter & Gamble’s delivery seems stark, long-term health sound, and “despite all that spending” there’s maybe some upside to estimates yet.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PG:
- Procter & Gamble price target raised to $173 from $170 at Deutsche Bank
- Procter & Gamble price target raised to $172 from $164 at JPMorgan
- Procter & Gamble (NYSE:PG) Ticks Higher on Strong Sales, Margin Expansion
- Procter & Gamble: Promotional environment ‘stable,’ no interest in changing it
- Procter & Gamble says ‘still navigating through plenty of challenges’
